Detailed answers about INNOVATIVE HEALTHCARE SOLUTIONS LTD, including incorporation, status, business activity, and accounts information.
When was INNOVATIVE HEALTHCARE SOLUTIONS LTD founded?
INNOVATIVE HEALTHCARE SOLUTIONS LTD was officially incorporated on 28 April 2025 and is registered under company number 16413562. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is INNOVATIVE HEALTHCARE SOLUTIONS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of INNOVATIVE HEALTHCARE SOLUTIONS LTD?
INNOVATIVE HEALTHCARE SOLUTIONS LTD's current status is Active - Proposal to Strike off. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does INNOVATIVE HEALTHCARE SOLUTIONS LTD do?
INNOVATIVE HEALTHCARE SOLUTIONS LTD operates in the following sectors: 70229 - Management consultancy activities other than financial management, 86101 - Hospital activities, 86220 - Specialists medical practice activities, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is INNOVATIVE HEALTHCARE SOLUTIONS LTD's registered address?
The registered office address of INNOVATIVE HEALTHCARE SOLUTIONS LTD is 20 WENLOCK ROAD, LONDON, ENGLAND, N1 7GU. This is the official address filed with Companies House for legal and statutory correspondence.
Is INNOVATIVE HEALTHCARE SOLUTIONS LTD financially stable?
Financial accounts for INNOVATIVE HEALTHCARE SOLUTIONS LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.